Novabay Pharmaceuticals, INC. (NBY) — DEFA14A Filings

All DEFA14A filings from Novabay Pharmaceuticals, INC.. Browse 11 DEFA14A reports with AI-powered summaries and risk analysis.

DEFA14A Filings (11)

NovaBay Pharma Files Proxy Solicitation Material — Mar 7, 2025 Risk: medium
NovaBay Pharmaceuticals, Inc. filed a DEFA14A on March 7, 2025, related to a previous 8-K filing from March 4, 2025. This filing is soliciting material under Ru
NovaBay Pharma Files DEFA14A for Soliciting Material — Feb 4, 2025 Risk: low
NovaBay Pharmaceuticals, Inc. filed a DEFA14A on February 4, 2025, related to soliciting material under Rule 14a-12 of the Exchange Act. The filing indicates th
NovaBay Sells Eyecare Business, Adjourns Shareholder Meeting — Jan 23, 2025 Risk: medium
NovaBay Pharmaceuticals, Inc. filed a DEFA14A on January 23, 2025, announcing the completion of its Eyecare business sale to PRN. The company also announced the
NovaBay Pharma Stockholder Meeting Vote Urgently Needed — Dec 11, 2024 Risk: low
NovaBay Pharmaceuticals, Inc. filed a Definitive Additional Materials (DEFA14A) on December 11, 2024, regarding its reconvened Special Meeting of Stockholders.
NovaBay CEO Urges FOR Vote at Special Meeting — Dec 9, 2024 Risk: medium
NovaBay Pharmaceuticals, Inc. (NBY) has filed a Definitive Additional Materials proxy statement (DEFA14A) on December 9, 2024. The filing includes a letter from
NovaBay Pharmaceuticals Special Meeting Adjourned — Nov 26, 2024 Risk: medium
NovaBay Pharmaceuticals, Inc. filed a Definitive Additional Materials document (DEFA14A) on November 26, 2024, regarding a special meeting of stockholders. The
ISS Backs NovaBay's Avenova Sale Proposals — Nov 15, 2024 Risk: low
NovaBay Pharmaceuticals, Inc. filed a DEFA14A on November 15, 2024, related to its upcoming shareholder meeting. The filing highlights that the prominent proxy
NovaBay Pharmaceuticals Urges Shareholder Vote — Nov 13, 2024 Risk: low
NovaBay Pharmaceuticals, Inc. filed a Definitive Additional Materials (DEFA14A) on November 13, 2024, related to its proxy statement. The filing indicates that
NovaBay Urges Shareholders to Vote — Nov 12, 2024 Risk: low
NovaBay Pharmaceuticals, Inc. filed a Definitive Additional Materials (DEFA14A) on November 12, 2024, reminding shareholders to vote their shares. The filing ur
NovaBay Pharmaceuticals Files Proxy Materials — Nov 6, 2024 Risk: low
NovaBay Pharmaceuticals, Inc. filed a Definitive Additional Materials (DEFA14A) on November 6, 2024. This filing relates to materials provided to shareholders,
NovaBay Pharmaceuticals Files DEFA14A — Oct 29, 2024 Risk: low
NovaBay Pharmaceuticals, Inc. filed a Definitive Additional Materials (DEFA14A) on October 29, 2024. This filing is related to their proxy statement and indicat

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX